Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid decompensation
and respiratory failure with elevated inflammatory markers, consistent with cytokine …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient-…

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …

Although sarcopenia (muscle loss) is associated with increased mortality after liver
transplantation, its influence on other complications is less well understood. We examined the …

We describe a case of proven transmission of SARS‐CoV‐2 from lung donor to recipient.
The donor had no clinical history or findings suggestive of infection with SARS‐CoV‐2 and …

The aim of this document is to provide a concise scientific review of the currently available
COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …

Background. To improve our understanding of risk factors, management, diagnosis, and
outcomes associated with histoplasmosis after solid organ transplant (SOT), we report a large …

Infection is a major complication of hematopoietic cell transplantation. Prolonged neutropenia
and graft-versus-host disease are the 2 major complications with an associated risk for …

Despite clinical and laboratory screening of potential donors for transmissible disease,
unexpected transmission of disease from donor to recipient remains an inherent risk of organ …